Document is current
Any future updates will be listed below
-
Authors
Ilagan, Crisanta H. https://orcid.org/0000-0001-7013-0634
Goldman, Debra A.
Gönen, Mithat
Aveson, Victoria G.
Babicky, Michelle
Balachandran, Vinod P.
Drebin, Jeffrey A.
Jarnagin, William R.
Wei, Alice C.
Kingham, T. Peter
Abou-Alfa, Ghassan K.
Brown, Karen T.
D’Angelica, Michael I.
- License Information
-
More Information
Article History
First Online: 8 August 2022
Disclosures
: GAA reports research support from Arcus, Agios, AstraZeneca, BioNtech, BMS, Celgene, Flatiron, Genentech/Roche, Genoscience, Incyte, Polaris, Puma, QED, Silenseed, Yiviva; and consulting support from Adicet, Alnylam, AstraZeneca, Autem, Bayer, Beigene, Berry Genomics, Celgene, Cend, CytomX, Eisai, Eli Lilly, Exelixis, Flatiron, Genentech/Roche, Genoscience, Helio, Incyte, Ipsen, Legend Biotech, Merck, Nerviano, QED, Redhill, Rafael, Servier, Silenseed, Sobi, Surface Oncology, Therabionics, Vector, and Yiviva. PCT/US2014/031545 filed on March 24, 2014, and priority application Serial No.: 61/804,907; Filed: March 25, 2013. DG is a current employee of Regeneron Pharmaceuticals and receives restricted stock as a form of compensation. AW reports consulting for Histosonics, Biosapien; honoraria for teaching for Medtronic, AstraZeneca; travel for Intuitive Surgical and Bayer. Other authors have no relevant conflicts of interest to report.
